Impact of Workforce-Oriented Performance-based Funding on Students’ Return on Investment
American Educational Research Journal · 06.11.2026
DOI: 10.3102/00028312261493445 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Educational Research Journal, online erschienen am 06.11.2026. Verfasst von William Zahran und 5 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
States are increasingly using workforce-oriented performance-based funding (PBF) to fund higher education and incentivize colleges and universities to improve students’ postgraduation outcomes. In this study we use detailed up-to-date data on workforce-oriented PBF policies in the United States combined with publicly available College Scorecard data to estimate the effect of PBF on students’ return on investment, as measured by debt-to-earnings ratios and loan default rates. We find that workforce-oriented PBF has minimal effects on students’ debt-to-earnings ratios and loan defaults except at historically Black colleges and universities, where we find suggestive evidence that workforce-oriented PBF reduced student debt.
Zitieren
APA
Zahran, W., Ortagus, J. C., Choi, J., Allchin, H., Rosinger, K., & Kelchen, R. (2026). Impact of Workforce-Oriented Performance-based Funding on Students’ Return on Investment. American Educational Research Journal. https://doi.org/10.3102/00028312261493445
Vancouver
Zahran W, Ortagus JC, Choi J, Allchin H, Rosinger K, Kelchen R. Impact of Workforce-Oriented Performance-based Funding on Students’ Return on Investment. American Educational Research Journal. 2026. doi:10.3102/00028312261493445
BibTeX
@article{Zahran2026,
author = {Zahran, William and Ortagus, Justin C. and Choi, Junghee and Allchin, Hope and Rosinger, Kelly and Kelchen, Robert},
title = {Impact of Workforce-Oriented Performance-based Funding on Students’ Return on Investment},
journal = {American Educational Research Journal},
year = {2026},
doi = {10.3102/00028312261493445}
}
EUVIMED